Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: MeNZB
Active Ingredient: Neisseria meningitidis group B (strain NZ98/254) 25Ág/dose
Dosage Form: Suspension for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Chiron S.r.l, Bellaria, Rosia, Sovicille, Italy
Note: This consent is given subject to the following condition:
? This vaccine is for use in individuals aged six months or older.
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 7th day of July 2004.
KAREN POUTASI, Director-General of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).